Takeda Pharmaceutical Co. Ltd. (TAK) Phase 3 PANTHER (Pevonedistat-3001) Trial Did Not Achieve Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HUBS

Go back to Takeda Pharmaceutical Co. Ltd. (TAK) Phase 3 PANTHER (Pevonedistat-3001) Trial Did Not Achieve Primary Endpoint
(NYSE: TAK) Delayed: 18.45 -0.26 (1.39%)
Previous Close $18.71    52 Week High $0.55 
Open $18.48    52 Week Low $0.55 
Day High $18.54    P/E N/A 
Day Low $18.39    EPS $-0.20 
Volume 1,499,548